Chapter LXXII: Egészségbiztosítási Alap (Health Insurance Fund)

Overview

Chapter LXXII is the Egészségbiztosítási Alap (Health Insurance Fund, hereafter E. Alap), Hungary’s compulsory social health insurance fund. It is one of the two major parastate social insurance funds, alongside the Nyugdíjbiztosítási Alap (Pension Fund, Chapter LXXIII). The fund finances a broad spectrum of compulsory public healthcare benefits: cash transfers (sick pay, maternity/paternity allowances, disability benefits), in-kind curative services (GP care, specialist outpatient and inpatient care, pharmaceuticals, medical devices), and the administrative apparatus of the health insurance bureaucracy.

The 2026 budget is notionally balanced: both total expenditure and total revenue are set at 4,945,568.6 millió Ft. The operational budget (Hazai működési) shows kiadás of 4,945,342.6 millió Ft against bevétel of 4,945,568.6 millió Ft, with a trivial capital budget (226.0 millió Ft expenditure, zero revenue). The chapter therefore runs a marginal operational surplus of 226.0 millió Ft, which is absorbed by the capital deficit, producing a net zero balance.

The fund is almost entirely dependent on compulsory payroll-linked contributions (TB járulék, egészségbiztosítási járulék, szociális hozzájárulási adó) plus large general-budget transfers. This makes it one of the most fiscally significant chapters in the national budget, representing roughly 12-13% of consolidated central government expenditure.

---

Revenue Items

1/1. Szociális hozzájárulási adó E. Alapot megillető része (Social Contribution Tax — Health Fund Portion)

• Current yield: 621,642.3 millió Ft
• Type: Payroll tax (employer-side)
• Current rate: 13% of gross wages, paid by employers; the share allocated to the E. Alap is a fixed statutory fraction of total szocho revenue
• Incidence: Economically borne by workers in the form of lower gross wages and by employers in the form of higher total labour costs. Szocho raises the wedge between the marginal product of labour and the worker’s net take-home pay.
• Distortion rank: 2 (high distortion — reduces labour demand and formal employment, encourages grey-market work and tax optimisation through non-wage compensation)
• Notes: This item would shrink automatically if labour market interventions are eliminated and the formal employment base expands, but it would not disappear. A liberalised labour market would likely increase the tax base even at a lower rate.

1/2. Társadalombiztosítási járulék E. Alapot megillető része és egészségbiztosítási járulék (Social Insurance Contribution — Health Fund Portion and Health Insurance Contribution)

• Current yield: 2,231,800.0 millió Ft
• Type: Payroll tax (employee-side)
• Current rate: 18.5% TB járulék paid by employees; the E. Alap receives the health-insurance portion (7% of the 18.5%)
• Incidence: Nominally employee-borne, but standard tax incidence theory (and Austrian labour market analysis) holds that the true burden is shared between employee and employer depending on supply/demand elasticities.
• Distortion rank: 2 (same category as szocho — compulsory health insurance contributions are a tax on formal employment)
• Notes: This is the single largest revenue item in the chapter, comprising 45% of total fund revenue. Reduction would require either a transition to private voluntary health insurance or a structural realignment of the fund’s expenditure obligations.

1/3. Egyéb járulékok és hozzájárulások (Other Contributions and Levies)

• Current yield: 123,500.0 millió Ft
• Type: Quasi-tax contributions (various)
• Notes: Includes contributions from the self-employed, simplified employment arrangements (egyszerűsített foglalkoztatás), and other special-category contributors. The economic incidence is analogous to standard payroll contributions.

1/5. Késedelmi pótlék, bírság (Late Payment Surcharges and Fines)

• Current yield: 5,900.0 millió Ft
• Type: Penalty/fine revenue
• Notes: Enforcement receipts from non-compliant contributors. Minor in scale.

1/6/6. Járulék címen átvett pénzeszköz (Funds Transferred as Contribution Revenue)

• Current yield: 730,391.6 millió Ft
• Type: General budget transfer (treated as quasi-contribution)
• Notes: This large inter-budget transfer reflects the state’s obligation to pay health contributions on behalf of persons who are not in employment (children, pensioners, recipients of state allowances). It is effectively a disguised subsidy from the central budget to the fund, masking the actuarial imbalance of the system.

1/6/10. Kiadások támogatására tervezett pénzeszköz-átvétel, egészségügyi feladatok ellátásával kapcsolatos költségvetési hozzájárulás (Budget Contribution for Healthcare Task Funding)

• Current yield: 981,608.2 millió Ft
• Type: Direct general government subsidy to the health fund
• Notes: This is the second-largest revenue item and represents an explicit acknowledgement that contribution revenues do not cover the fund’s expenditures. This 981 billion Ft subsidy is a direct transfer from tax revenue, obscuring the true fiscal cost of the national health insurance system from contributors.

1/7. Baleseti és egyéb kártérítési megtérítések (Accident and Other Damage Reimbursements)

• Current yield: 10,954.1 millió Ft
• Type: Third-party reimbursements / fee
• Notes: Recoveries from third parties (e.g., insurance companies) liable for accidents. Would diminish if the fund’s expenditure scope is narrowed.

1/8. Gyógyszergyártók és forgalmazók befizetései (Pharmaceutical Manufacturer and Distributor Payments)

• Current yield: 132,441.2 millió Ft combined (41,446.3 + 90,992.9 + 1.0 + 1.0)
• Type: Industry regulatory levy / negotiated rebate
• Notes: Pharmaceutical companies pay statutory rebates on subsidised drug sales. These are a form of price regulation. From an Austrian perspective, they represent a symptom of the underlying price control embedded in the drug subsidy system. If the subsidy system were wound down, these revenues would disappear.

1/9. Nemzetközi egyezményből eredő ellátások megtérítése (Reimbursements under International Agreements)

• Current yield: 9,504.5 millió Ft
• Type: EU/bilateral agreement reimbursements
• Notes: Cross-border healthcare cost recoveries under EU Regulation 883/2004 and bilateral treaties.

1/10. Egészségügyi szolgáltatók visszafizetése (Healthcare Provider Repayments)

• Current yield: 280.0 millió Ft
• Type: Repayment/clawback fee
• Notes: Clawback of overpayments to providers. Minor in scale.

1/12. Népegészségügyi termékadó (Public Health Product Tax, NETA)

• Current yield: 96,900.0 millió Ft
• Type: Excise/sin tax
• Current rate: Varies by product category: soft drinks ~8-23 Ft/liter; syrups 105-310 Ft/liter; high-sugar snacks and energy drinks at product-specific per-unit rates
• Incidence: Borne by consumers of sugary drinks, salty snacks, energy drinks, and similar products. A regressive tax in the sense that lower-income households spend a higher share of income on NETA-subject goods.
• Distortion rank: 3 (moderate distortion — the paternalistic justification for sin taxes is inconsistent with Austrian subjective value theory; individuals are better placed than the state to weigh the costs and benefits of their consumption choices; however, the tax distortion is smaller per forint than payroll taxes since it targets a narrow category)
• Notes: NETA revenues flow directly to the E. Alap, notionally to offset the healthcare costs of lifestyle diseases. This is a circular argument: the fund creates demand for NETA as a revenue source, and NETA perpetuates the fund. Revenue would be lost if the fund’s mandate is narrowed.

Cim 3. Vagyongazdálkodás (Asset Management — Revenue)

• Current yield: 46.7 millió Ft
• Type: Property income / fee
• Notes: Trivial asset management receipts.

Cim 5/1. Központi hivatali szerv (Central Administrative Body — Revenue)

• Current yield: 600.0 millió Ft
• Type: Fee revenue
• Notes: Administrative fees charged by the central insurance administration. Would disappear if the fund is privatised.

---

Expenditure Analysis

Cim 2/1. Csecsemőgondozási díj — CSED (Infant Care Allowance / Maternity Benefit)

• Current allocation: 182,603.8 millió Ft
• Classification: Phase-Out (7 years)
• Rationale: CSED is a compulsory cash replacement benefit paid at 100% of the mother’s prior earnings for 168 days following birth (as of 2025 reform). The underlying problem it addresses — the income shock of childbearing — is real, but the mandated provision crowds out voluntary private solutions (employer maternity schemes, private savings, family support networks). From the Austrian calculation standpoint, centrally mandated benefit parameters cannot reflect the heterogeneous time-preferences of individual families.
• Transition mechanism: Year 1-2: Freeze replacement rate at current level; allow employer top-up via tax-free private arrangements. Year 3-4: Reduce statutory replacement rate to 70%. Year 5-7: Convert to a means-tested transitional benefit, then fully privatise via employer-negotiated or insurance-backed schemes.
• Affected groups: Mothers of newborns in insured employment; approximately 80,000-90,000 beneficiaries annually. Short-term disruption would be significant if transition is abrupt.

Cim 2/2. Táppénz (Sick Pay)

• Current allocation: 266,560.8 millió Ft
• Classification: Phase-Out (5 years)
• Rationale: Compulsory sick pay at 60-70% of earnings (depending on insurance period) is funded through the E. Alap but administered by employers. It represents a classic Rothbardian forced wealth transfer: healthy workers subsidise sick workers through a non-voluntary pooling arrangement. Private disability and income-protection insurance markets can and do provide superior risk-calibrated coverage. The mandated minimum distorts labour contracts and creates moral hazard (absenteeism).
• Transition mechanism: Year 1-2: Transfer administrative burden fully to employers with partial state reimbursement tapering off. Year 3-4: Mandate only a minimum first-week employer-paid sick day obligation (private, not state). Year 5: Remove statutory state obligation entirely; allow labour market to determine sick pay through collective agreements and private insurance.
• Affected groups: All insured employees; approximately 1-1.5 million annual claimants. Private income-protection insurance is available but currently underdeveloped; a 5-year transition is needed for market deepening.

Cim 2/3. Egyszeri segély (One-Time Aid Payment)

• Current allocation: 450.0 millió Ft
• Classification: Immediate Cut
• Rationale: A residual lump-sum grant category within the health insurance system. At 450 millió Ft, the administrative cost of means-testing, processing, and distributing these payments likely approaches or exceeds the economic benefit delivered. This is precisely the type of small, high-overhead, politically-marginal transfer that Austrian public choice analysis identifies as institutional rent-seeking preserved by bureaucratic inertia rather than genuine welfare need.
• Transition mechanism: Eliminate in a single budget cycle. Any genuine hardship cases can be absorbed into the transitional emergency safety net.
• Affected groups: Small number of recipients of one-time hardship payments from the health fund; the amount is so modest that alternative private charitable channels could absorb the need.

Cim 2/4. Kártérítési és baleseti járadék (Accident and Damages Pension)

• Current allocation: 12,529.2 millió Ft
• Classification: Phase-Out (5 years)
• Rationale: Periodic accident compensation payments arising from historical work injuries and liability cases. These are essentially legacy commitments from the state-socialist era’s workplace liability framework. While legitimate from a contract-enforcement standpoint (the state incurred these liabilities), the long-run solution is a private workers’ compensation insurance market, not perpetual state provision. Existing beneficiaries have vested expectations that must be honoured through a structured wind-down.
• Transition mechanism: Honour all existing claims in full through a lump-sum capitalised settlement or continued payment for the remaining individual entitlement periods. New claims (from 2027 onward) to be handled through mandatory private occupational accident insurance. Full phase-out as legacy population ages out, targeting 5 years.
• Affected groups: Current recipients of periodic accident compensation; primarily older workers with historical industrial injuries.

Cim 2/5. Gyermekgondozási díj és örökbefogadói díj — GYED (Child Care Allowance and Adoption Allowance)

• Current allocation: 457,002.0 millió Ft
• Classification: Phase-Out (7 years)
• Rationale: GYED pays 70% of prior earnings (capped at twice the minimum wage) for up to 2 years per child. This is the second-largest cash benefit in the chapter. While the intent — supporting parental care — reflects genuine family preferences, the centralised compulsory mechanism socialises the costs of child-rearing broadly, including among childless workers, creating cross-subsidies that distort labour market participation and family formation decisions. The Austrian argument is that families are better judges of how to finance the transition to parenthood than central planners.
• Transition mechanism: Years 1-2: Cap the benefit at the current monetary ceiling with no nominal increase. Years 3-5: Convert to a time-limited bridge payment for parents who cannot access employer-based or private GYED-equivalent schemes. Years 5-7: Full privatisation; remove statutory obligation from the E. Alap; employer and private insurance markets to provide parental income replacement.
• Affected groups: Parents in insured employment with children under 2 years old; approximately 130,000-150,000 current beneficiaries. The financial impact on families is large and must be front-loaded with private market development.

Cim 2/6. Rokkantsági, rehabilitációs ellátások (Disability and Rehabilitation Benefits)

• Current allocation: 419,852.3 millió Ft
• Classification: Phase-Out (10 years)
• Rationale: Disability benefits address genuine incapacity arising from illness or injury that prevents labour market participation. This is arguably the most complex category from a transitional perspective. Austrian economics does not deny the reality of involuntary disability; the question is whether state provision is more efficient and less distortionary than private disability insurance and charity. The scale — 419 billion Ft — reflects decades of accumulated entitlements, many of which embed significant moral hazard (disability rolls expand during recessions as a shadow unemployment benefit).
• Transition mechanism: Year 1-3: Strict reassessment of all current beneficiaries against objective medical criteria; terminate benefits for those who are employable with reasonable accommodation. Year 3-5: Require new disability cases to draw on mandatory private disability insurance (analogous to the German Berufsunfahigkeitsversicherung). Year 5-10: Taper state disability benefit for existing beneficiaries; replace with private insurance or means-tested emergency welfare.
• Affected groups: Approximately 400,000-500,000 current disability benefit recipients. This is the most politically sensitive transition item in the chapter. Transition costs are real and significant; savings are real but slow to materialise.

Cim 2/7. Gyógyító-megelőző ellátás (Curative and Preventive Healthcare — aggregate)

The largest expenditure category in the chapter. Several sub-programmes require individual assessment.

2/7/1. Háziorvosi, háziorvosi ügyeleti ellátás (GP and GP Out-of-Hours Care)

• Current allocation: 296,534.0 millió Ft
• Classification: Phase-Out (5 years)
• Rationale: Primary care (house calls and GP-level care) is financed through a capitation system from the E. Alap. GPs are effectively state contractors. This arrangement suppresses price signals: patients have no cost feedback on consumption, and GP income is not tied to quality or patient satisfaction. The result is chronic under-investment in primary care quality despite substantial public expenditure. A voucher-based or user-pays model with means-tested assistance for low-income patients would allocate resources more efficiently.
• Transition mechanism: Years 1-2: Introduce co-payments for GP visits above a minimum threshold. Years 3-4: Convert GPs to independent private contractors with optional insurance coverage. Year 5: Full primary care market; means-tested vouchers for low-income patients; emergency care carve-out retained.
• Affected groups: All Hungarian residents; 9-10 million potential users. Transition must preserve access for elderly and low-income populations during the adjustment period.

2/7/2. Védőnői szolgáltatás, anya-, gyermek- és ifjúságvédelem (Public Health Nurse Service, Mother and Child Protection)

• Current allocation: 27,283.3 millió Ft
• Classification: Phase-Out (5 years)
• Rationale: The védőnői (public health visitor/nurse) network provides maternal and child health monitoring. This overlaps with GP functions. A transition to a private healthcare market would incorporate these services naturally via paediatricians and midwives operating in a fee-for-service or insurance environment.
• Transition mechanism: Integrate with GP privatisation. Retain a residual emergency/emergency-referral function for the transition period as part of the minimal safety net.
• Affected groups: Mothers with infants and young children; rural communities with limited GP access are most dependent.

2/7/3. Fogászati ellátás (Dental Care)

• Current allocation: 86,612.2 millió Ft
• Classification: Phase-Out (3 years)
• Rationale: Dental care is one of the areas where private markets already function in parallel with the public system in Hungary, and where the public system is widely acknowledged to be chronically underfunded and low-quality. This is a textbook illustration of Hayek’s knowledge problem: central allocation cannot match the quality or diversity of private provision. Private dental practices already dominate elective and quality care; the residual public system addresses only basic and emergency dental care.
• Transition mechanism: Year 1: Limit public funding to emergency dental procedures only; all elective and routine care referred to the private market. Years 2-3: Phase out public dental funding entirely; retain emergency dental within the minimal emergency safety net.
• Affected groups: Lower-income households who rely on public dental subsidies. Co-payments already exist; removal of subsidy would increase out-of-pocket costs. A transitional means-tested voucher is advisable.

2/7/4. Otthoni szakápolás (Home Nursing Care)

• Current allocation: 12,980.8 millió Ft
• Classification: Phase-Out (5 years)
• Rationale: Home nursing is a specialised service with a genuine private market equivalent. Insurance-based and self-pay home care already exists. State provision crowds out private home care agencies.
• Transition mechanism: Years 1-3: Introduce means testing for state-funded home nursing. Years 4-5: Full privatisation; only means-tested vouchers for low-income elderly patients.
• Affected groups: Elderly and chronically ill patients; their family caregivers.

2/7/5. Betegszállítás és orvosi rendelvényű halottszállítás (Patient Transport and Medical Corpse Transport)

• Current allocation: 12,852.3 millió Ft
• Classification: Phase-Out (3 years)
• Rationale: Non-emergency patient transport is a logistics service that can be provided competitively by private operators. State provision via the E. Alap suppresses competitive entry.
• Transition mechanism: Year 1: Open competitive tendering for patient transport contracts. Years 2-3: Remove E. Alap financing; integrate with private healthcare insurance or direct user payment.
• Affected groups: Patients requiring regular transport (e.g., dialysis patients). This group is also served by the Mentés (ambulance) line below.

2/7/6. Művesekezelés (Dialysis Treatment)

• Current allocation: 38,771.1 millió Ft
• Classification: Phase-Out (7 years)
• Rationale: Dialysis is life-sustaining treatment for renal failure patients. From an Austrian perspective, this falls at the boundary between the minimal emergency safety net and a chronic disease management programme. It is retained in the phase-out category rather than keep because private dialysis provision (with insurance coverage) is fully feasible and produces superior quality outcomes. However, the transition must be managed carefully to avoid patient harm.
• Transition mechanism: Years 1-3: Require new renal failure patients to enrol in private dialysis insurance; state continues to fund existing patients. Years 4-7: As private market deepens, existing state-funded patients migrate to insurance coverage. After 7 years, residual truly uninsurable cases absorbed into means-tested emergency provision.
• Affected groups: Approximately 6,000-8,000 dialysis-dependent patients. Life-critical dependency makes this the most sensitive phase-out in this sub-category.

2/7/7. Célelőirányzatok (Targeted Appropriations within Összevont szakellátás)

• Current allocation: 974,641.9 millió Ft (aggregate of multiple sub-items under Összevont szakellátás and ancillary lines)

This aggregate encompasses the core specialist and hospital care financing, broken down as:

• Járóbeteg-szakellátás (Outpatient specialist care): 221,118.0
• Népegészségügy fejlesztése (Public health development): 2,717.5
• Többletkapacitás befogadás (Surplus capacity funding): 4,000.0
• Működési előleg (Operational advance): 2,000.0
• PCR molekuláris diagnosztika (PCR diagnostics): 10,802.1
• Fekvőbeteg-szakellátás (Inpatient hospital care): 762,602.0
• Extrafinanszírozás (Extra financing): 1,000.0
• Speciális finanszírozású szakellátás (Specialty-financed specialist care): 74,382.8

Outpatient specialist care (Járóbeteg-szakellátás)

• Current allocation: 221,118.0 millió Ft
• Classification: Phase-Out (7 years)
• Rationale: Outpatient specialist care is the primary care step above the GP level. The same analysis applies as for GP care: centrally-set fee schedules, absence of price signals, and distorted demand.

Inpatient hospital care (Fekvőbeteg-szakellátás)

• Current allocation: 762,602.0 millió Ft
• Classification: Phase-Out (7 years)
• Rationale: The single largest expenditure line. Hungary’s hospitalisation rate and average length of stay are significantly above EU averages, reflecting the distorted demand inherent in zero-price public hospital care. Austrian economics predicts that a price-clearing hospital market, supplemented by private insurance, would produce shorter stays, more appropriate triage, and better resource allocation. Emergency and trauma care (keep category) must be ring-fenced.
• Transition mechanism: Years 1-3: Introduce hospital co-payments for non-emergency admissions; allow private hospital entry with reduced regulatory burden. Years 4-7: Convert public hospitals to independent trusts or privatise; insurance-based financing replaces E. Alap capitation. Emergency wards remain publicly funded under the minimal safety net.
• Affected groups: All patients requiring specialist or hospital care — essentially the entire population. The transition has the widest scope of any single line item in this chapter.

Speciális finanszírozású szakellátás (Specialty-financed specialist care)

• Current allocation: 74,382.8 millió Ft
• Classification: Phase-Out (7 years)
• Rationale: Highly specialist procedures (oncology, complex surgery, etc.) with specific financing arrangements. Private specialist insurance markets exist for these services in comparable economies.

Mentés (Ambulance/Emergency Medical Services)

• Current allocation: 45,781.5 millió Ft
• Classification: Keep
• Rationale: Emergency ambulance response falls squarely within the Austrian minimal state’s permissible emergency safety net (accident and trauma care). Emergency medical services prevent irreversible harm to life and limb and cannot be effectively priced at the point of use without producing catastrophic outcomes. This is one of the few legitimate E. Alap expenditures under the night-watchman framework.
• Transition mechanism: No change proposed. Efficiency improvements through competitive tendering for non-emergency components are advisable.
• Affected groups: All citizens.

Laboratóriumi ellátás (Laboratory Diagnostics)

• Current allocation: 30,295.6 millió Ft
• Classification: Phase-Out (5 years)
• Rationale: Diagnostic laboratory services are a competitive market service. Private laboratories operate throughout Hungary. State-funded laboratory services at zero cost to the patient generate excessive demand.
• Transition mechanism: Years 1-2: Introduce co-payments for non-urgent lab tests. Years 3-5: Convert state labs to private operators; financing through insurance.
• Affected groups: All patients requiring diagnostic tests.

Nagyértékű gyógyszerfinanszírozás (High-Cost Drug Financing)

• Current allocation: 195,000.0 millió Ft
• Classification: Phase-Out (7 years)
• Rationale: Public funding of high-cost oncology, biological, and rare-disease drugs is one of the most politically contested areas of health policy. From an Austrian standpoint, centralised drug approval and subsidy decisions replace market pricing with bureaucratic allocation, systematically under-providing drugs with uncertain evidence bases and over-providing politically favoured treatments. Private high-cost drug insurance and voluntary risk pools are feasible.
• Transition mechanism: Years 1-3: Require private insurance for newly approved high-cost drugs; existing beneficiaries continue at current state funding levels. Years 4-7: Market-based pricing with private insurance; means-tested state subsidy only for genuine poverty cases.
• Affected groups: Patients with cancer, rare diseases, and autoimmune conditions who receive high-cost biological therapies.

Egészségügyi kiegészítő finanszírozás (Supplementary Healthcare Financing)

• Current allocation: 80,000.0 millió Ft
• Classification: Phase-Out (5 years)
• Rationale: This line covers top-up payments to healthcare providers beyond standard tariff rates. It is an explicit acknowledgement that the central tariff system under-prices actual costs. Rather than adjusting prices (which would expose the full cost of state healthcare), the state layers supplementary grants on top. This creates a hidden subsidy with no transparent cost-benefit accountability.
• Transition mechanism: Years 1-2: Freeze at current level. Years 3-5: Phase out as providers transition to market-based pricing and insurance reimbursement.
• Affected groups: Healthcare providers and their patients.

Céltartalék items (Gyógyító-megelőző ellátás céltartalék: 7,460.1)

• Classification: Immediate Cut
• Rationale: Reserve appropriations within the healthcare system represent contingency funding for unanticipated provider demands. Under a transition to market provision, there is no justification for a state-held reserve; providers hold their own reserves.

Egyéb minor items (Népegészségügy fejlesztése: 2,717.5; Többletkapacitás: 4,000.0; Működési előleg: 2,000.0; Extrafinanszírozás: 1,000.0; PCR: 10,802.1)

• Classification: Immediate Cut (Többletkapacitás, Működési előleg, Extrafinanszírozás) / Phase-Out 3 years (Népegészségügy fejlesztése, PCR)
• Rationale: Surplus capacity funding (Többletkapacitás), operational advance loans (Működési előleg), and extrafinancing top-ups are pure provider subsidies with no clear outcome accountability. PCR diagnostics and public health development have transitional value but should be privatised as the broader health market develops.

Cim 2/8. Gyógyfürdő és egyéb gyógyászati ellátás támogatása (Spa and Medical Balneology Subsidies)

• Current allocation: 2,514.2 millió Ft
• Classification: Immediate Cut
• Rationale: Subsidised spa and balneology treatment through the state health insurance fund is a non-emergency, non-essential service where a fully developed private commercial market already exists. Hungary’s thermal bath industry is one of the country’s most commercially successful sectors. State subsidy to a commercially viable industry constitutes corporate welfare and distorts competitive pricing.
• Transition mechanism: Eliminate in a single budget cycle. Medically necessary hydrotherapy remains available via GP referral to private facilities, unsubsidised.
• Affected groups: Patients using spa treatments under medical referral; spa operators currently receiving subsidised patients. The commercial spa market will absorb demand at market prices.

Cim 2/9. Anyatej-ellátás (Human Milk Supply Programme)

• Current allocation: 200.0 millió Ft
• Classification: Immediate Cut
• Rationale: At 200 millió Ft, this is a trivial appropriation. State funding of human milk banks is a micro-programme that could be sustained entirely through voluntary charitable donations, private hospital foundations, or fees. The administrative cost of managing this as a separate budget line likely approximates its value.
• Transition mechanism: Transfer to private hospital or charity management. Eliminate from E. Alap budget.
• Affected groups: Premature neonates requiring donor human milk. Continuity of supply must be assured through voluntary charity before elimination.

Cim 2/10. Gyógyszertámogatás (Drug Subsidy Programme)

• Total allocation: 566,862.5 millió Ft (kiadások 434,423.3 + céltartalék 132,439.2)
• Classification: Phase-Out (7 years)
• Rationale: Hungary’s pharmaceutical subsidy system uses a tiered reference pricing model that subsidises drugs in defined therapeutic categories by 25-100% of their retail price. The system produces predictable Austrian inefficiencies: (1) patients over-consume drugs relative to their true willingness to pay; (2) the pricing distorts pharmaceutical company R&D incentives; (3) bureaucratic gatekeeping replaces consumer-driven choice; (4) the rebate mechanism (1/8 revenues above) creates a price-control enforcement apparatus. The subsidy reserve (céltartalék) adds an additional 132 billion Ft in contingency that indicates systematic budget instability.
• Transition mechanism: Year 1-2: Remove subsidies from off-patent generic drugs where competition already produces low prices. Years 3-5: Transition branded drug subsidies to income-tested vouchers. Years 5-7: Remove all statutory drug subsidies; private health insurance covers drug costs; means-tested emergency provision for genuine poverty.
• Affected groups: All pharmaceutical consumers — approximately 8-9 million prescription drug users. Pensioners and chronically ill patients are the most subsidy-dependent.

Cim 2/11. Gyógyászati segédeszköz támogatás (Medical Device Subsidy)

• Total allocation: 81,525.1 millió Ft (64,558.1 + 16,967.0)
• Classification: Phase-Out (5 years)
• Rationale: Subsidies for wheelchairs, prosthetics, hearing aids, orthotics, and other medical devices create the same demand distortions as drug subsidies. A private insurance market for medical devices already exists in most comparable economies. The state subsidy suppresses market price discovery and crowds out competitive device provision.
• Transition mechanism: Years 1-3: Means-test all device subsidies; remove subsidies for devices available at low cost in the open market. Years 4-5: Transition to private insurance coverage; retain emergency provision for catastrophic need.
• Affected groups: Disabled and chronically ill patients requiring assistive devices.

Cim 2/13. Utazási költségtérítés (Travel Cost Reimbursement for Healthcare)

• Current allocation: 6,161.3 millió Ft
• Classification: Immediate Cut
• Rationale: State reimbursement of travel costs to and from healthcare appointments is an administrative overhead that generates significant fraud exposure and creates perverse incentives to attend services. This is precisely the type of auxiliary benefit that an Austrian analysis identifies as an unintended consequence of a broader price-distorting system: when care is nominally free, travel costs become the only user-facing cost, so the state feels obliged to eliminate those too.
• Transition mechanism: Eliminate as part of broader co-payment reform.
• Affected groups: Patients traveling to specialist appointments; rural patients disproportionately affected. Partially offsetting reduction in overuse justifies elimination.

Cim 2/14. Nemzetközi egyezményből eredő és külföldön tervezett ellátások (International Agreement and Planned Foreign Healthcare)

• Total allocation: 30,365.2 millió Ft (27,039.2 + 106.0 + 3,220.0)
• Classification: Nominal Freeze
• Rationale: Emergency healthcare costs incurred abroad under EU Regulation 883/2004 (sürgősségi ellátás, 27,039.2) are a treaty obligation and cannot be unilaterally eliminated. Planned foreign medical care reimbursements are a separate category that could be reduced. The emergency component is consistent with the minimal safety net.
• Transition mechanism: Freeze total allocation at current nominal level. Separately cap elective foreign treatment reimbursements and eliminate the 3,220.0 millió Ft category over 3 years.
• Affected groups: Hungarian citizens receiving emergency care abroad; patients seeking specialist treatment unavailable domestically.

Cim 2/15. Természetbeni ellátások céltartaléka (In-Kind Benefit Reserve)

• Current allocation: 3,000.0 millió Ft
• Classification: Immediate Cut
• Rationale: A reserve fund for unexpected in-kind benefit demands. Under the proposed transition, the scope of in-kind benefits is being systematically reduced; maintaining a reserve for a shrinking category is unjustified.
• Transition mechanism: Eliminate immediately.
• Affected groups: None directly; the reserve is unused in normal circumstances.

Cim 2/16. Egyéb ellátásokhoz kapcsolódó kiadások (Other Benefit-Related Expenditures)

• Total allocation: 20,218.4 millió Ft (6,178.7 + 5,004.5 + 235.2 + 8,800.0)
• Classification: Phase-Out (5 years) for most sub-items; Immediate Cut for minor line items

Sub-items:

• Kifizetőhelyeket megillető költségtérítés (Payer site administrative reimbursement): 6,178.7 — Phase-Out (5 years): These are reimbursements to employers for administering sick pay and maternity benefits. As those programmes are phased out, this administrative overhead disappears automatically.
• Postaköltség (Postage costs): 5,004.5 — Phase-Out (5 years): Postal costs for benefit cheque/documentation distribution. Migrates to digital delivery as part of broader government digitisation; eliminated as the fund’s scope narrows.
• Egyéb kiadások (Miscellaneous expenditures): 235.2 — Immediate Cut: Residual miscellaneous line; no specific programme justification.
• Gyógyszertárak juttatása és szolgáltatási díja (Pharmacy service fee): 8,800.0 — Phase-Out (5 years): The state currently pays pharmacies a dispensing fee for public subsidy processing. This fee disappears as the drug subsidy programme is phased out.

Cim 3. Vagyongazdálkodás (Asset Management — Expenditure)

• Current allocation: 5.7 millió Ft (expenditure)
• Classification: Nominal Freeze
• Rationale: Trivial asset maintenance. Cannot be cut without affecting functional infrastructure.
• Transition mechanism: Maintain at current nominal level.
• Affected groups: E. Alap administration.

Cim 5. Egészségbiztosítási költségvetési szervek — Központi hivatal (Health Insurance Administrative Body — Central Office)

• Total allocation: 8,882.9 millió Ft (Személyi juttatások 5,960.8 + járulékok 863.1 + dologi 1,653.0 + egyéb 180.0 + beruházás 226.0)
• Classification: Phase-Out (7 years)
• Rationale: The central health insurance bureaucracy — the Nemzeti Egészségbiztosítási Alapkezelő (NEAK) and its predecessor bodies — administers the fund’s payment and contracting functions. Under the proposed transition, as the fund’s scope is progressively narrowed, the administrative apparatus must shrink proportionally. A pure emergency-care fund would require a fraction of the current administrative structure. The bureaucracy itself has a strong institutional incentive to resist transition — a textbook public choice observation.
• Transition mechanism: Years 1-3: Reduce headcount by 30% as benefit administration is transferred to private insurers. Years 4-7: Retain only a regulatory oversight and audit function; convert to a small arm of the Ministry of Finance.
• Affected groups: NEAK employees (several thousand civil servants); healthcare providers dependent on NEAK contracting and payment.

---

Chapter Summary

Classification	Count	Total (millió Ft)
Immediate Cut	8	19,653.9
Phase-Out	24	4,814,024.3
Nominal Freeze	3	33,371.5
Keep	1	45,781.5
Total	36	4,912,831.2

Note: Rounding and aggregation of sub-items account for a small difference versus the chapter total of 4,945,568.6 millió Ft; the remaining 32,737.4 millió Ft represents minor line items grouped within parent categories above.

Revenue	Total (millió Ft)
Total chapter revenue	4,945,568.6
Of which: payroll/contribution taxes	2,976,942.3
Of which: general budget subsidy	1,711,999.8
Of which: NETA (sin tax)	96,900.0
Of which: pharmaceutical industry levies	132,441.2
Of which: other/minor	27,285.3

---

Key Observations

• The chapter’s notional balance (kiadás = bevétel = 4,945,568.6 millió Ft) conceals a structural deficit: approximately 1,711,999.8 millió Ft (35% of the fund) is covered by general budget transfers, not actuarial contributions. This is a socialised subsidy hidden within the insurance fund architecture.

• The largest single expenditure cluster is hospital inpatient care (762,602.0 millió Ft), which in the absence of price signals generates systematically excessive admission rates and lengths of stay compared to comparable insurance-based systems. The seen cost is the stated allocation; the unseen cost is the private healthcare investment that would have occurred in a competitive market.

• Cash benefit programmes (CSED, GYED, táppénz, rokkantsági ellátások) together account for approximately 1,338,548.7 millió Ft — 27% of total fund expenditure. These programmes collectively replace labour market income through a compulsory pooling mechanism that crowds out private insurance, employer arrangements, and family savings.

• The pharmaceutical subsidy system (566,862.5 millió Ft in direct spending, partially offset by 132,441.2 millió Ft in pharmaceutical industry rebates) creates a circular: state subsidies inflate drug demand, which generates pharma rebate revenue back to the fund, which finances further subsidies. The Misesian calculation problem applies in full: without market prices, the fund cannot know whether a given drug subsidy is producing health outcomes worth their cost.

• NETA (96,900.0 millió Ft) represents a paternalistic attempt to use tax policy to modify consumption of certain foods and beverages. From a subjective value standpoint, there is no basis for the state to determine that consumers’ revealed preferences for sugary drinks are sub-optimal. The tax’s proceeds flowing to the fund creates a perverse incentive: the E. Alap has a fiscal interest in NETA revenue, meaning it has an institutional interest in continued consumption of NETA-subject goods — precisely the consumption it claims to be discouraging.

• The E. Alap’s administrative body (NEAK) budget of 8,882.9 millió Ft is a small fraction of total fund spending but represents the command-and-control mechanism that allocates the entire 4.9 trillion Ft. The ratio of administrative overhead to total allocated funds is artificially low because providers bear the bulk of administrative compliance costs (the unseen administrative cost of the system).

• Emergency ambulance services (45,781.5 millió Ft) is the only expenditure line fully consistent with the Austrian night-watchman framework. All other lines require either immediate elimination or structured multi-year transition to private provision.

• The projected Year 1 fiscal saving from Immediate Cut items alone is approximately 19,653.9 millió Ft — modest relative to the fund’s total size, reflecting that the most significant savings require the longer phase-out transitions. Full transition savings over 10 years would eliminate virtually the entire fund’s expenditure obligations (minus emergency care), representing a potential 4.9 trillion Ft annual reallocation to private market activity.